Table 1.
Characteristics of study samples and univariate analysis stratified by HCC treatment status.
| Characteristics | Total (N = 65) | HCC treated with TACE (N = 35) | HCC without treatment (N = 30) | P-value |
|---|---|---|---|---|
| Age (years) | 59.4 ± 6.3 | 59.7 ± 6.9 | 59.1 ± 5.6 | 0.7430a |
| Sex | ||||
| Male | 46 (70.8) | 24 (68.6) | 22 (73.3) | 0.6739b |
| Female | 19 (29.2) | 11 (31.4) | 8 (26.7) | |
| Cause of HCC | ||||
| HBV | 12 (18.5) | 6 (17.1) | 6 (20.0) | 0.9096c |
| HCV | 37 (56.9) | 20 (57.2) | 17 (56.7) | |
| Alcohol | 4 (6.1) | 3 (8.6) | 1 (3.3) | |
| Cryptogenic | 12 (18.5) | 6 (17.1) | 6 (20.0) |
Data are shown as N (%) or means ± standard deviation (SD).
a
P-value from independent sample t-test
b
P-value from chi-square test
c
P-value from Fisher’s exact test.
Abbreviations: HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization; HBV, hepatitis B virus; HCV, hepatitis C virus.